Compare MCS & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCS | LMRI |
|---|---|---|
| Founded | 1935 | 2018 |
| Country | United States | United States |
| Employees | N/A | 4335 |
| Industry | Movies/Entertainment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.9M | 781.1M |
| IPO Year | 1994 | N/A |
| Metric | MCS | LMRI |
|---|---|---|
| Price | $23.82 | $9.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $23.33 | $20.75 |
| AVG Volume (30 Days) | 194.8K | ★ 736.2K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $758,458,000.00 | N/A |
| Revenue This Year | $12.05 | $6.35 |
| Revenue Next Year | $3.15 | $5.61 |
| P/E Ratio | $30.34 | ★ N/A |
| Revenue Growth | ★ 3.11 | N/A |
| 52 Week Low | $12.85 | $6.45 |
| 52 Week High | $24.34 | $19.45 |
| Indicator | MCS | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 76.60 | 58.06 |
| Support Level | $14.96 | $8.82 |
| Resistance Level | N/A | $10.38 |
| Average True Range (ATR) | 0.85 | 0.68 |
| MACD | 0.29 | 0.16 |
| Stochastic Oscillator | 94.93 | 78.46 |
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.